Soluble Fibrin Monomer Complex Kit
Nanopia SF
We created this page for medical staff.
- *Read carefully the package insert before use.
Performance Data
Within-run reproducibility
| Sample 1 | Sample 2 | |
|---|---|---|
| n | 10 | 10 |
| Mean | 11.23 | 51.63 |
| S.D. | 0.07 | 1.35 |
| C.V. (%) | 0.64 | 2.62 |
| Max. | 11.31 | 54.59 |
| Min. | 11.09 | 50.57 |
| Range | 0.22 | 4.02 |
Interference
| Interfering substances | Concentration | Measured Value (µg/mL) | |
|---|---|---|---|
| Base Plasma | Spiked Plasma | ||
| Unconjugated Bilirubin | 20 mg/dL | 23.5 | 24.0 |
| Conjugated Bilirubin | 20 mg/dL | 23.3 | 23.5 |
| Hemoglobin | 100 mg/dL | 23.0 | 24.9 |
| Chyle | 2000 FTU | 24.5 | 22.9 |
Assay procedure
"Nanopia" is a trademark or registered trademark of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.
"Coapresta" and all related logos are trademarks or registered trademarks of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.
We prepared this page for medical staff (doctors, dentists, pharmacists, clinical laboratory technicians, nurses, etc.) in Japan to ensure the correct use of our products. You should be aware that the information provided is not intended for overseas medical staff and the general public.